Qube Research & Technologies (QRT)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-13,152
Closed -$400K 3146
2022
Q2
$400K Buy
+13,152
New +$400K ﹤0.01% 1482
2022
Q1
Sell
-17,810
Closed -$470K 3162
2021
Q4
$470K Buy
+17,810
New +$470K ﹤0.01% 1604
2020
Q3
Sell
-37,720
Closed -$5.89M 2206
2020
Q2
$5.89M Buy
+37,720
New +$5.89M 0.09% 300